Eyeworld Daily News

EW SHOW DAILY 14 He will trace those innovations in the lecture, including an aspect of IOL development important to the lecture itself. "One of the main people in Europe who was involved in the various designs of IOLs was Dr. Binkhorst," Dr. Mamalis said. "Cornelius Binkhorst [MD] designed variations on different iris- fixated IOLs; I'm going to spend some time talking about the evolu- tion of IOLs and how they went from lenses that were fixated to the iris to different designs of lenses that were in the anterior chamber, and then, eventually, going back to the posterior chamber, where we put IOLs now." Lecture conclusion Dr. Mamalis said he will discuss different IOL materials, designs, and technologies currently on the mar- ket, and issues in accommodation and restoring full vision following cataract surgery. In addition, he will look into the future, highlighting research into new kinds of materials and ac- commodating lenses. Another topic discussed will be the potential for an injectable IOL, which could closely mimic the way the crystalline lens works in the human eye. "I think the conclusion is going to be that we have come a long way from the earliest attempts at design- ing an IOL by Sir Ridley and that's been more than 60 years now. Over the past 60 years, the IOL design, the material and finishes have evolved greatly, and I think the main conclusion is going to be we've come a long way but we've still got a ways to go," Dr. Mamalis said. EW Editors' note: Dr. Mamalis has finan- cial interests with Abbott Medical Optics (AMO, Santa Ana, Calif.), Alcon (Fort Worth, Texas), Allergan (Irvine, Calif.), ARC Laser (Nuremberg, Germany), Anew Optics (Newton, Mass.), Bausch + Lomb (Rochester, N.Y.), Calhoun Vision (Pasadena, Calif.), MBI (Pomona, Calif.), Meden- nium (Irvine, Calif.), NuView (San Diego), Ophthalmic Innovations International (Ontario, Calif.), and OptiMedica (Sunnyvale, Calif.). Saturday, April 20, 2013 ASCRS News Today T his year's Binkhorst Lecture honoree, Nick Mamalis, MD, is looking forward to highlighting a topic of great interest to him in the lecture: the history of the intraocu- lar lens. "This is an exciting area, and even though we've undergone a tremendous evolution, there's still room for improvement, and there's still a ways we have to go in the fu- ture," said Dr. Mamalis, professor of ophthalmology, John A. Moran Eye Center, Department of Ophthalmol- ogy & Visual Sciences, University of Utah, Salt Lake City. Dr. Mamalis will present this year's Binkhorst Lecture, "Intraocu- lar Lens Evolution: What a Long, Strange Trip it's Been," at the ASCRS Opening General Session today from 10 a.m. to 11:45 a.m. "I'll talk about different ways of accomplishing restoration of accom- modation and restoration of near and intermediate vision in addition to distance vision after cataract surgery," he said. "That's what I'm going to cover—what is being looked at right now and what is in the near future that we're going to be looking at to try to improve pa- tients' vision after cataract surgery." He said being selected to give the lecture was a great honor. "I think it is truly one of the highest honors you can receive from ASCRS to be chosen to give the Binkhorst Lecture so I'm very ex- cited, and at the same time very humbled that I was chosen to give this lecture," Dr. Mamalis said. "When I look at the list of the peo- ple who have given the Binkhorst Lecture over the last couple of decades, it really is a "who's who" of people who have done a tremendous amount of work in the area of cataract and refractive surgery." History of IOLs Dr. Mamalis will begin the Binkhorst Lecture at the invention of the IOL, with inventor Sir Harold Ridley, MD, and his observation of Royal Air Force (RAF) pilot injuries during World War II. "My mentor David Apple [MD] did a lot of research with Sir Ridley and wrote a book about him," Dr. Mamalis said. "It was Sir Ridley's ex- perience treating RAF fighter pilots, where they would get shattered bits of cockpit in their eye [that led to the invention of the IOL]. It just for- tuitously worked out that the cock- pit was made of Plexiglas, which is PMMA, which was the original ma- terial that he chose for making the first IOL. The reason was, this mate- rial, he found, was inert and did not cause inflammation when it was inside the fighter pilots' eyes." Sir Ridley performed the first successful IOL surgery in England in 1950, and following that, IOL inno- vations spread across Europe in the 1960s and 1970s, Dr. Mamalis said. Binkhorst Lecture to examine past, present, future of IOLs by Erin L. Boyle EyeWorld Senior Staff Writer Abbott announces FDA approval and U.S. launch of the TECNIS Toric intraocular lens A bbott (Abbott Park, Ill.) announced that the TECNIS Toric 1- Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) approval and is launching in the U.S. for the treatment of cataract patients with pre-existing corneal astigmatism. Unlike conventional IOLs, the TECNIS Toric 1-Piece IOL can correct a patient's loss of focus due to pre-existing corneal astigmatism of one diopter or greater. "The TECNIS Toric 1-Piece IOL represents the latest advancement in cataract technology and expands Abbott's portfolio of the TECNIS family of IOLs," said Murthy Simhambhatla, senior vice president, Abbott Medical Optics. "The TECNIS Toric 1-Piece IOL allows surgeons to offer an additional lens option that provides proven visual outcomes to increase patient satisfaction." Along with delivering precise visual outcomes for patients, rota- tional stability is an important attribute of a toric IOL. The TECNIS Toric 1-piece IOL remains stable once inserted into the eye and meets the new standard for toric IOL rotational stability, as approved by the American National Standards Institute (ANSI). In addition to providing astigmatism correction, the TECNIS Toric 1-Piece lens minimizes imprecise light focusing (spherical aberration) to provide sharper distance vision for the patient. "The TECNIS Toric IOL decreases astigmatism while improving visual quality, with improved functional vision," said Kevin Waltz, MD, Eye Surgeons of Indiana, and clinical investigator for the TECNIS Toric IOL. "Having implanted several TECNIS Toric IOLs within clinical trials, I find it delivers excellent patient results." Additional information about the TECNIS Toric 1-Piece IOL, including important safety information, is available at www.tecnistoriciol.com. Breaking news Nick Mamalis, MD

• Cover